icon-folder.gif   Conference Reports for NATAP  
 
 

AASLD

The Liver Meeting
Washington DC
October 2017
Back grey_arrow_rt.gif
 
 
 
Impact of Hepatocellular Carcinoma (HCC) and Tumor Treatment on Sustained Virologic Response (SVR) Rates with Direct-Acting Antiviral (DAA) Therapy for Hepatitis C: HCV-TARGET Results
 
 
  Reported by Jules Levin
AASLD Annual Meeting 2017, Washington, DC, USA, October 20-24
 
Kavita Radhakrishnan1, Adrian M. Di Bisceglie2, K. Rajender Reddy3, Joseph K. Lim4, Josh Levitsky5, Alexander Kuo6, Mohamed A. Hassan7, Jama M. Darling8,
Jordan J. Feld9, Lucy Akushevich8, Monika Vainorius8, David R. Nelson10, Michael W. Fried8, Robert S. Brown11, Norah Terrault1
1. University of California, San Francisco 2. Saint Louis University School of Medicine 3. University of Pennsylvania. 4. Yale University School of Medicine 5. Northwestern University, 6. Virginia Mason Medical Center 7. University of Minnesota 8. University of North Carolina Chapel Hill, 9. Toronto Western Hospital Liver Center. 10. University of Florida, Gainesville,11. Weill Cornell Medical School

1120171

1120172

1120173

1120174

1120175

1120176

 

1120177